nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—endothelium—malignant glioma	0.0683	0.196	CbGeAlD
Plerixafor—CXCR4—blood vessel—malignant glioma	0.063	0.181	CbGeAlD
Plerixafor—CXCR4—embryo—malignant glioma	0.0376	0.108	CbGeAlD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—MDK—malignant glioma	0.0356	0.0635	CbGpPWpGaD
Plerixafor—CXCR4—retina—malignant glioma	0.0332	0.0954	CbGeAlD
Plerixafor—CXCR4—telencephalon—malignant glioma	0.0306	0.0878	CbGeAlD
Plerixafor—CXCR4—medulla oblongata—malignant glioma	0.024	0.069	CbGeAlD
Plerixafor—CXCR4—midbrain—malignant glioma	0.022	0.063	CbGeAlD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—CSF1—malignant glioma	0.0218	0.0388	CbGpPWpGaD
Plerixafor—CXCR4—S1P3 pathway—FLT1—malignant glioma	0.0216	0.0386	CbGpPWpGaD
Plerixafor—CXCR4—spinal cord—malignant glioma	0.0214	0.0615	CbGeAlD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—TNC—malignant glioma	0.0202	0.036	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—MYB—malignant glioma	0.0199	0.0354	CbGpPWpGaD
Plerixafor—CXCR4—central nervous system—malignant glioma	0.0174	0.0499	CbGeAlD
Plerixafor—CXCR4—cerebellum—malignant glioma	0.017	0.0488	CbGeAlD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—NDRG1—malignant glioma	0.017	0.0302	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCR4—malignant glioma	0.0158	0.0281	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—SOX2—malignant glioma	0.0153	0.0273	CbGpPWpGaD
Plerixafor—CXCR4—brain—malignant glioma	0.0138	0.0396	CbGeAlD
Plerixafor—CXCR4—S1P3 pathway—PDGFB—malignant glioma	0.0133	0.0238	CbGpPWpGaD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—PTK2—malignant glioma	0.013	0.0232	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—CCR4—malignant glioma	0.0126	0.0225	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CXCR3—malignant glioma	0.0117	0.0209	CbGpPWpGaD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—FGFR1—malignant glioma	0.0109	0.0194	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—TFRC—malignant glioma	0.0105	0.0187	CbGpPWpGaD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—F2—malignant glioma	0.00986	0.0176	CbGpPWpGaD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—FN1—malignant glioma	0.00986	0.0176	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—CXCR3—malignant glioma	0.00938	0.0167	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—BDKRB2—malignant glioma	0.00858	0.0153	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—PDGFRA—malignant glioma	0.00813	0.0145	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—NOTCH1—malignant glioma	0.00808	0.0144	CbGpPWpGaD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—FGF2—malignant glioma	0.00795	0.0142	CbGpPWpGaD
Plerixafor—CXCR4—S1P3 pathway—VEGFA—malignant glioma	0.00688	0.0123	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—KDR—malignant glioma	0.00684	0.0122	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—NOTCH1—malignant glioma	0.00645	0.0115	CbGpPWpGaD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—MMP9—malignant glioma	0.00629	0.0112	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.00628	0.0112	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—PTK2—malignant glioma	0.00601	0.0107	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	0.006	0.0107	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCR4—malignant glioma	0.00594	0.0106	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL1B—malignant glioma	0.00558	0.00995	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—FGF2—malignant glioma	0.00531	0.00946	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCR4—malignant glioma	0.00501	0.00893	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CCR4—malignant glioma	0.00465	0.00829	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—BAD—malignant glioma	0.0045	0.00803	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CXCL8—malignant glioma	0.00444	0.00792	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CXCR3—malignant glioma	0.00441	0.00787	CbGpPWpGaD
Plerixafor—CXCR4—S1P3 pathway—AKT1—malignant glioma	0.00439	0.00783	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—PIK3CG—malignant glioma	0.00436	0.00778	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—PTPN11—malignant glioma	0.00429	0.00764	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—BDKRB2—malignant glioma	0.00403	0.00719	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00398	0.0071	CbGpPWpGaD
Plerixafor—Injection site reaction—Carmustine—malignant glioma	0.00386	0.0425	CcSEcCtD
Plerixafor—Musculoskeletal pain—Temozolomide—malignant glioma	0.0038	0.0418	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—CXCR3—malignant glioma	0.00372	0.00664	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—KNG1—malignant glioma	0.00367	0.00654	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.00345	0.00616	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—BDKRB2—malignant glioma	0.0034	0.00607	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—PIK3CB—malignant glioma	0.00334	0.00596	CbGpPWpGaD
Plerixafor—Swelling—Carmustine—malignant glioma	0.0032	0.0352	CcSEcCtD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.00316	0.00564	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.00316	0.00563	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—KNG1—malignant glioma	0.0031	0.00552	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCR4—malignant glioma	0.00303	0.00541	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00296	0.00528	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—MMP9—malignant glioma	0.00291	0.00518	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00271	0.00483	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LATS2—malignant glioma	0.00259	0.00462	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—STAT3—malignant glioma	0.00258	0.00461	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00246	0.00439	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—HLA-A—malignant glioma	0.00243	0.00434	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—F2—malignant glioma	0.00237	0.00423	CbGpPWpGaD
Plerixafor—Abdominal distension—Temozolomide—malignant glioma	0.00237	0.0261	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—CXCR3—malignant glioma	0.00225	0.00402	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—BDKRB2—malignant glioma	0.00206	0.00367	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—PIK3CA—malignant glioma	0.00204	0.00363	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.00202	0.0036	CbGpPWpGaD
Plerixafor—CXCR4—Disease—BCAN—malignant glioma	0.002	0.00356	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LATS1—malignant glioma	0.00196	0.0035	CbGpPWpGaD
Plerixafor—Haemoglobin—Carmustine—malignant glioma	0.00196	0.0216	CcSEcCtD
Plerixafor—Haemorrhage—Carmustine—malignant glioma	0.00195	0.0215	CcSEcCtD
Plerixafor—Connective tissue disorder—Carmustine—malignant glioma	0.00192	0.0211	CcSEcCtD
Plerixafor—Haemoglobin—Temozolomide—malignant glioma	0.00189	0.0209	CcSEcCtD
Plerixafor—Haemorrhage—Temozolomide—malignant glioma	0.00188	0.0208	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—KNG1—malignant glioma	0.00187	0.00334	CbGpPWpGaD
Plerixafor—Connective tissue disorder—Temozolomide—malignant glioma	0.00185	0.0204	CcSEcCtD
Plerixafor—CXCR4—Disease—DTX1—malignant glioma	0.00181	0.00322	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCR4—malignant glioma	0.00171	0.00305	CbGpPWpGaD
Plerixafor—Mental disorder—Carmustine—malignant glioma	0.00171	0.0188	CcSEcCtD
Plerixafor—Immune system disorder—Temozolomide—malignant glioma	0.0017	0.0187	CcSEcCtD
Plerixafor—Erythema—Carmustine—malignant glioma	0.0017	0.0187	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CXCL8—malignant glioma	0.00167	0.00298	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—AKT1—malignant glioma	0.00166	0.00297	CbGpPWpGaD
Plerixafor—Mental disorder—Temozolomide—malignant glioma	0.00165	0.0182	CcSEcCtD
Plerixafor—Erythema—Temozolomide—malignant glioma	0.00164	0.0181	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.00159	0.00284	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCR4—malignant glioma	0.00156	0.00277	CbGpPWpGaD
Plerixafor—Ill-defined disorder—Temozolomide—malignant glioma	0.00152	0.0168	CcSEcCtD
Plerixafor—Malaise—Temozolomide—malignant glioma	0.00148	0.0163	CcSEcCtD
Plerixafor—CXCR4—Disease—HEY2—malignant glioma	0.00142	0.00253	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CXCL8—malignant glioma	0.00141	0.00251	CbGpPWpGaD
Plerixafor—Arthralgia—Temozolomide—malignant glioma	0.0014	0.0154	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00139	0.0153	CcSEcCtD
Plerixafor—CXCR4—Disease—IDH1—malignant glioma	0.00138	0.00247	CbGpPWpGaD
Plerixafor—Discomfort—Temozolomide—malignant glioma	0.00138	0.0152	CcSEcCtD
Plerixafor—Dry mouth—Temozolomide—malignant glioma	0.00137	0.015	CcSEcCtD
Plerixafor—Anaphylactic shock—Temozolomide—malignant glioma	0.00134	0.0147	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—MDK—malignant glioma	0.00133	0.00236	CbGpPWpGaD
Plerixafor—Nervous system disorder—Temozolomide—malignant glioma	0.00131	0.0145	CcSEcCtD
Plerixafor—CXCR4—Disease—HEY1—malignant glioma	0.00131	0.00234	CbGpPWpGaD
Plerixafor—Skin disorder—Temozolomide—malignant glioma	0.0013	0.0143	CcSEcCtD
Plerixafor—Hyperhidrosis—Temozolomide—malignant glioma	0.00129	0.0143	CcSEcCtD
Plerixafor—CXCR4—Disease—HIST1H3B—malignant glioma	0.00128	0.00227	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CXCR3—malignant glioma	0.00127	0.00227	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—DTX1—malignant glioma	0.00126	0.00226	CbGpPWpGaD
Plerixafor—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00126	0.0139	CcSEcCtD
Plerixafor—Insomnia—Carmustine—malignant glioma	0.00125	0.0138	CcSEcCtD
Plerixafor—Paraesthesia—Carmustine—malignant glioma	0.00124	0.0137	CcSEcCtD
Plerixafor—Dyspnoea—Carmustine—malignant glioma	0.00124	0.0136	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00122	0.0134	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—F2—malignant glioma	0.00121	0.00216	CbGpPWpGaD
Plerixafor—Insomnia—Temozolomide—malignant glioma	0.00121	0.0133	CcSEcCtD
Plerixafor—Paraesthesia—Temozolomide—malignant glioma	0.0012	0.0132	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Carmustine—malignant glioma	0.0012	0.0132	CcSEcCtD
Plerixafor—Dyspnoea—Temozolomide—malignant glioma	0.00119	0.0131	CcSEcCtD
Plerixafor—Constipation—Carmustine—malignant glioma	0.00118	0.013	CcSEcCtD
Plerixafor—Pain—Carmustine—malignant glioma	0.00118	0.013	CcSEcCtD
Plerixafor—Dyspepsia—Temozolomide—malignant glioma	0.00118	0.013	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—BDKRB2—malignant glioma	0.00116	0.00208	CbGpPWpGaD
Plerixafor—CXCR4—Disease—JAG2—malignant glioma	0.00116	0.00208	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CXCR3—malignant glioma	0.00116	0.00206	CbGpPWpGaD
Plerixafor—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00116	0.0127	CcSEcCtD
Plerixafor—Fatigue—Temozolomide—malignant glioma	0.00115	0.0127	CcSEcCtD
Plerixafor—Pain—Temozolomide—malignant glioma	0.00115	0.0126	CcSEcCtD
Plerixafor—Constipation—Temozolomide—malignant glioma	0.00115	0.0126	CcSEcCtD
Plerixafor—Feeling abnormal—Carmustine—malignant glioma	0.00114	0.0126	CcSEcCtD
Plerixafor—Gastrointestinal pain—Carmustine—malignant glioma	0.00113	0.0125	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.00112	0.002	CbGpPWpGaD
Plerixafor—Feeling abnormal—Temozolomide—malignant glioma	0.0011	0.0122	CcSEcCtD
Plerixafor—Abdominal pain—Carmustine—malignant glioma	0.0011	0.0121	CcSEcCtD
Plerixafor—Gastrointestinal pain—Temozolomide—malignant glioma	0.0011	0.0121	CcSEcCtD
Plerixafor—Urticaria—Temozolomide—malignant glioma	0.00106	0.0117	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—KNG1—malignant glioma	0.00106	0.00189	CbGpPWpGaD
Plerixafor—Abdominal pain—Temozolomide—malignant glioma	0.00106	0.0117	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—BDKRB2—malignant glioma	0.00106	0.00189	CbGpPWpGaD
Plerixafor—Hypersensitivity—Carmustine—malignant glioma	0.00102	0.0112	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—SUFU—malignant glioma	0.001	0.00179	CbGpPWpGaD
Plerixafor—Asthenia—Carmustine—malignant glioma	0.000994	0.0109	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—HEY2—malignant glioma	0.000993	0.00177	CbGpPWpGaD
Plerixafor—Hypersensitivity—Temozolomide—malignant glioma	0.000987	0.0109	CcSEcCtD
Plerixafor—CXCR4—Disease—H3F3A—malignant glioma	0.000985	0.00176	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GFAP—malignant glioma	0.00097	0.00173	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—KNG1—malignant glioma	0.000962	0.00172	CbGpPWpGaD
Plerixafor—Asthenia—Temozolomide—malignant glioma	0.000961	0.0106	CcSEcCtD
Plerixafor—Diarrhoea—Carmustine—malignant glioma	0.000948	0.0104	CcSEcCtD
Plerixafor—Pruritus—Temozolomide—malignant glioma	0.000947	0.0104	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—SPHK1—malignant glioma	0.000938	0.00167	CbGpPWpGaD
Plerixafor—CXCR4—Disease—JAG1—malignant glioma	0.000929	0.00166	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCR4—malignant glioma	0.000919	0.00164	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HEY1—malignant glioma	0.000919	0.00164	CbGpPWpGaD
Plerixafor—Dizziness—Carmustine—malignant glioma	0.000916	0.0101	CcSEcCtD
Plerixafor—Diarrhoea—Temozolomide—malignant glioma	0.000916	0.0101	CcSEcCtD
Plerixafor—CXCR4—Disease—FBXW7—malignant glioma	0.00091	0.00162	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HIST1H3B—malignant glioma	0.000893	0.00159	CbGpPWpGaD
Plerixafor—Dizziness—Temozolomide—malignant glioma	0.000886	0.00975	CcSEcCtD
Plerixafor—Vomiting—Carmustine—malignant glioma	0.000881	0.0097	CcSEcCtD
Plerixafor—Rash—Carmustine—malignant glioma	0.000874	0.00962	CcSEcCtD
Plerixafor—Dermatitis—Carmustine—malignant glioma	0.000873	0.00961	CcSEcCtD
Plerixafor—Headache—Carmustine—malignant glioma	0.000868	0.00956	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—CXCL8—malignant glioma	0.000854	0.00152	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—MMP3—malignant glioma	0.000852	0.00152	CbGpPWpGaD
Plerixafor—Vomiting—Temozolomide—malignant glioma	0.000851	0.00938	CcSEcCtD
Plerixafor—Rash—Temozolomide—malignant glioma	0.000844	0.0093	CcSEcCtD
Plerixafor—Dermatitis—Temozolomide—malignant glioma	0.000844	0.00929	CcSEcCtD
Plerixafor—Headache—Temozolomide—malignant glioma	0.000839	0.00924	CcSEcCtD
Plerixafor—Nausea—Carmustine—malignant glioma	0.000823	0.00906	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—JAG2—malignant glioma	0.000815	0.00145	CbGpPWpGaD
Plerixafor—Nausea—Temozolomide—malignant glioma	0.000795	0.00876	CcSEcCtD
Plerixafor—CXCR4—Disease—CDKN2B—malignant glioma	0.000713	0.00127	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—H3F3A—malignant glioma	0.00069	0.00123	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—F2—malignant glioma	0.000685	0.00122	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCR3—malignant glioma	0.000683	0.00122	CbGpPWpGaD
Plerixafor—CXCR4—Disease—HES1—malignant glioma	0.00068	0.00121	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NCOR1—malignant glioma	0.000676	0.00121	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NTRK2—malignant glioma	0.000664	0.00118	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—YWHAE—malignant glioma	0.000664	0.00118	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FLT1—malignant glioma	0.000662	0.00118	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—DUSP6—malignant glioma	0.000659	0.00117	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PIK3CG—malignant glioma	0.000655	0.00117	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—JAG1—malignant glioma	0.00065	0.00116	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NOTCH3—malignant glioma	0.000648	0.00115	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PDGFRA—malignant glioma	0.000647	0.00115	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FBXW7—malignant glioma	0.000637	0.00114	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—BDKRB2—malignant glioma	0.000625	0.00111	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—F2—malignant glioma	0.000622	0.00111	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AKT2—malignant glioma	0.0006	0.00107	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TERT—malignant glioma	0.000596	0.00106	CbGpPWpGaD
Plerixafor—CXCR4—Disease—HLA-A—malignant glioma	0.000596	0.00106	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PIK3CG—malignant glioma	0.000595	0.00106	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PTPN11—malignant glioma	0.000585	0.00104	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PDGFB—malignant glioma	0.000582	0.00104	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NOTCH2—malignant glioma	0.000581	0.00104	CbGpPWpGaD
Plerixafor—CXCR4—Disease—FGFR1—malignant glioma	0.000579	0.00103	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PIK3CD—malignant glioma	0.000576	0.00103	CbGpPWpGaD
Plerixafor—CXCR4—Disease—HIF1A—malignant glioma	0.00057	0.00102	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—KNG1—malignant glioma	0.000568	0.00101	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CAV1—malignant glioma	0.000551	0.000983	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AKT2—malignant glioma	0.000545	0.000971	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NTRK1—malignant glioma	0.000542	0.000966	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PIK3CD—malignant glioma	0.000523	0.000933	CbGpPWpGaD
Plerixafor—CXCR4—Disease—BAD—malignant glioma	0.000518	0.000924	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOTCH1—malignant glioma	0.000513	0.000915	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MMP3—malignant glioma	0.000504	0.000898	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CD80—malignant glioma	0.000503	0.000897	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PIK3CB—malignant glioma	0.000502	0.000895	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APC—malignant glioma	0.000502	0.000895	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CDKN2B—malignant glioma	0.000499	0.00089	CbGpPWpGaD
Plerixafor—CXCR4—Disease—EGF—malignant glioma	0.000496	0.000885	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PTPN11—malignant glioma	0.000493	0.000879	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PTK2—malignant glioma	0.000485	0.000864	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL8—malignant glioma	0.000483	0.00086	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HES1—malignant glioma	0.000476	0.000849	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NCOR1—malignant glioma	0.000473	0.000844	CbGpPWpGaD
Plerixafor—CXCR4—Disease—BRAF—malignant glioma	0.000472	0.000841	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—RAF1—malignant glioma	0.000467	0.000833	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—IL2—malignant glioma	0.000461	0.000822	CbGpPWpGaD
Plerixafor—CXCR4—Disease—AKT2—malignant glioma	0.000459	0.000819	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PIK3CB—malignant glioma	0.000456	0.000813	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PDGFRA—malignant glioma	0.000453	0.000808	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PIK3CD—malignant glioma	0.000441	0.000787	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SPP1—malignant glioma	0.00044	0.000785	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CXCL8—malignant glioma	0.000438	0.000781	CbGpPWpGaD
Plerixafor—CXCR4—Disease—FGF2—malignant glioma	0.000423	0.000753	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL2—malignant glioma	0.000419	0.000747	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TERT—malignant glioma	0.000417	0.000744	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PDGFB—malignant glioma	0.000407	0.000726	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FGFR1—malignant glioma	0.000405	0.000722	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HIF1A—malignant glioma	0.000399	0.000712	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MDM2—malignant glioma	0.000395	0.000705	CbGpPWpGaD
Plerixafor—CXCR4—Disease—RAF1—malignant glioma	0.000394	0.000703	CbGpPWpGaD
Plerixafor—CXCR4—Disease—ERBB2—malignant glioma	0.00039	0.000695	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CAV1—malignant glioma	0.000386	0.000688	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PIK3CB—malignant glioma	0.000385	0.000686	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—KDR—malignant glioma	0.000382	0.000681	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PTGS2—malignant glioma	0.000381	0.00068	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—F2—malignant glioma	0.000367	0.000655	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FN1—malignant glioma	0.000367	0.000655	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—BAD—malignant glioma	0.000363	0.000647	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NOTCH1—malignant glioma	0.00036	0.000641	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CD80—malignant glioma	0.000352	0.000628	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PIK3CG—malignant glioma	0.000352	0.000627	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APC—malignant glioma	0.000352	0.000627	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—EGF—malignant glioma	0.000348	0.00062	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PTPN11—malignant glioma	0.000345	0.000616	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PTEN—malignant glioma	0.000332	0.000593	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—BRAF—malignant glioma	0.00033	0.000589	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AKT2—malignant glioma	0.000322	0.000574	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—EGFR—malignant glioma	0.00032	0.000571	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PIK3CD—malignant glioma	0.000309	0.000551	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PIK3CA—malignant glioma	0.000306	0.000546	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—KRAS—malignant glioma	0.000303	0.00054	CbGpPWpGaD
Plerixafor—CXCR4—Disease—STAT3—malignant glioma	0.000297	0.00053	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FGF2—malignant glioma	0.000296	0.000528	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PIK3CA—malignant glioma	0.000278	0.000496	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MDM2—malignant glioma	0.000277	0.000494	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MYC—malignant glioma	0.000276	0.000493	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RAF1—malignant glioma	0.000276	0.000492	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ERBB2—malignant glioma	0.000273	0.000487	CbGpPWpGaD
Plerixafor—CXCR4—Disease—EGFR—malignant glioma	0.00027	0.000482	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PIK3CB—malignant glioma	0.000269	0.00048	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCL8—malignant glioma	0.000259	0.000462	CbGpPWpGaD
Plerixafor—CXCR4—Disease—KRAS—malignant glioma	0.000255	0.000455	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AKT1—malignant glioma	0.00025	0.000446	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CASP3—malignant glioma	0.000248	0.000442	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL2—malignant glioma	0.000247	0.000441	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PIK3CA—malignant glioma	0.000235	0.000418	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MMP9—malignant glioma	0.000234	0.000418	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PTEN—malignant glioma	0.000233	0.000415	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AKT1—malignant glioma	0.000227	0.000405	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—VEGFA—malignant glioma	0.00021	0.000375	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—STAT3—malignant glioma	0.000208	0.000371	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MYC—malignant glioma	0.000193	0.000345	CbGpPWpGaD
Plerixafor—CXCR4—Disease—AKT1—malignant glioma	0.000192	0.000342	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—EGFR—malignant glioma	0.000189	0.000337	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—KRAS—malignant glioma	0.000179	0.000319	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PIK3CA—malignant glioma	0.000164	0.000293	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TP53—malignant glioma	0.000159	0.000283	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AKT1—malignant glioma	0.000134	0.000239	CbGpPWpGaD
